US Stock MarketDetailed Quotes
MCRB Seres Therapeutics
- 0.732
- -0.082-10.09%
Close Nov 21 16:00 ET
- 0.745
- +0.013+1.80%
Post 16:30 ET
124.95MMarket Cap-3484P/E (TTM)
0.880High0.723Low4.17MVolume0.830Open0.814Pre Close3.29MTurnover3.34%Turnover RatioLossP/E (Static)170.74MShares2.05052wk High5.23P/B91.37MFloat Cap0.54052wk Low--Dividend TTM124.86MShs Float52.000Historical High--Div YieldTTM19.27%Amplitude0.540Historical Low0.789Avg Price1Lot Size
About Seres Therapeutics Company
Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.
Company Profile
SymbolMCRB
Company NameSeres Therapeutics
Listing DateJun 26, 2015
Issue Price18.00
Founded2010
CEOMr. Eric D. Shaff
MarketNASDAQ
Employees233
Fiscal Year Ends12-31
Address200 Sidney Street,4th floor
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-617-945-9626
Company Executives
- Name
- Position
- Salary
- Eric D. Shaff
- Director, President, Chief Executive Officer, Interim Principal Financial Officer and Principal Accounting Officer
- 3.16M
- Dr. Teresa L. Young, PhD
- Executive Vice President, Chief Commercial and Strategy Officer
- 1.82M
- Dr. Matthew Henn, PhD
- Executive Vice President and Chief Scientific Officer
- --
- Dr. David S. Ege, PhD
- Executive Vice President and Chief Technology Officer
- --
- Thomas J. DesRosier
- Executive Vice President, Chief Legal Officer and Secretary
- --
- Dr. Lisa von Moltke, M.D.
- Executive Vice President and Chief Medical Officer
- 1.57M
- Stephen Berenson
- Chairman of the Board
- 249.23K
- Richard N. Kender, M.B.A.
- Independent Director
- 232.69K
- Dr. Dennis A. Ausiello, M.D.
- Independent Director
- 222.27K
- Paul R. Biondi
- Independent Director
- 211.73K
- Dr. Willard H. Dere, M.D.
- Independent Director
- 225.23K
- Dr. Claire M. Fraser, PhD
- Independent Director
- 438.15K
- Kurt C. Graves
- Independent Director
- 219.23K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
